Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity. (2020)
Attributed to:
Commercialisation of VR for biomolecular design
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d0sc06195f
PubMed Identifier: 34163906
Publication URI: http://europepmc.org/abstract/MED/34163906
Type: Journal Article/Review
Volume: 12
Parent Publication: Chemical science
Issue: 4
ISSN: 2041-6520